Astaxanthin Decreases Inflammatory Biomarkers Associated with Cardiovascular Disease in Human Umbilical Vein Endothelial Cells

Abstract

Oxidative stress and inflammation are strongly linked to the development of cardiovascular disease (CVD). As a potent antioxidant, astaxanthin may downregulate inflammation-associated factors involved in endothelial dysfunction and CVD progression. We studied the possible protective effects of astaxanthin against endothelial dysfunction in human umbilical vein endothelial cells (HUVEC) induced with hydrogen peroxide (H2O2). Cells were pre-incubated with 0, 0.01, 0.1, or 1.0 μmol/L astaxanthin for 48 h, then oxidative stress induced with 100 μmol/L H2O2 overnight. Uptake kinetics of astaxanthin showed a time-dependent uptake of astaxanthin (1.0 μmol/L) by HUVEC over the 48 h incubation period. Oxidative stress induction with H2O2 in HUVEC decreased intracellular antioxidant activity and increased the production of inflammatory biomarkers and reactive oxygen species (ROS). In contrast, pre-incubation of HUVEC with astaxanthin prior to H2O2 stress increased (P < 0.05) superoxide dismutase activity and decreased ROS, prostaglandin E2, leukotriene B4, NO, IL-8, and IFN- production. Pre-treatment with astaxanthin also downregulated the transcriptional activation of NF-κB and activator protein-1, thereby inhibiting downstream production of inflammatory mediators and cytokines. Therefore, astaxanthin protects against factors initiated by H2O2 addition, likely by scavenging ROS required for transcriptional activation and inhibiting the production of inflammatory biomarkers involved in endothelial dysfunction and CVD.Abbreviations: AP-1: activator protein-1; CVD: cardiovascular disease; CS: culture supernatant; EGM-2: endothelial growth medium-2; GPx: glutathione peroxidase; H2O2: hydrogen peroxide; HUVEC: human umbilical vein endothelial cell; LTB4: leukotriene B4; PGE2: prostaglandin E2; ROS: reactive oxygen species; SOD: superoxide dismutase; THF: tetrahydrofuran.

Cordycepin attenuates Salivary Hypofunction through the Prevention of Oxidative Stress in Human Submandibular Gland Cells

“…Oxidative stress is a main cause of cellular damage in several diseases, including xerostomia [40,41]. In addition to therapeutic interventions, bioactive compounds with antioxidant activity have been reported to be capable of protecting cells from oxidative stress [42,43]. The bioactive compound cordycepin has been previously reported to be effective against oxidative and endoplasmic reticulum stress by reducing intracellular ROS generation in vitro [15,44].…”

Astaxanthin blocks preeclampsia progression by suppressing oxidative stress and inflammation

“…This results in low permeabilization into cells and thus few studies have been conducted on its effects. However, Chew et al (26) found that astaxanthin does slowly permeate into cells, with a peak at 24-48 h, and thus may be a treatment candidate. In this study, H 2 O 2 was used to induce oxidative damage and astaxanthin treatment for 48 h was shown to effectively relieve H 2 O 2 -induced endothelial cell death, reduce the production of active oxygen, and protect the MMP.…”

Bioaccessibility of Marine Carotenoids

“…The consistency of these results points to assign a remarkable potential to astaxanthin as a bioactive compound that may decrease the risk of developing adverse diseases including cancer [ 67 ], gastric ulcers by Helicobacter pylori [ 75 ] and other gastrointestinal disorders [ 76 , 77 ]. Some studies claim the positive influence of astaxanthin in the gastrointestinal health [ 70 , 78 ] and as a therapeutic agent against cardiovascular disease [ 79 , 80 , 81 , 82 ]. The antioxidant activity of astaxanthin presents other collateral benefits in the enhancement of the immune system as it has been shown by in vitro and in vivo experimental animal models [ 65 ] and humans [ 83 ].…”